Galantamine protects against lipopolysaccharide-induced acute lung injury in rats

Lipopolysaccharide (LPS)-induced endotoxemia triggers the secretion of proinflammatory cytokines and can cause acute lung injury (ALI). The high mobility group box 1 (HMGB1) protein plays an important role as a late mediator of sepsis and ALI. Galantamine (GAL) is a central acetylcholinesterase inhibitor that inhibits the expression of HMGB1. This study evaluated the effects of GAL by measuring levels of inflammatory mediators and observing histopathological features associated with LPS-induced ALI. Sixty 8-10 week old male Sprague-Dawley rats (200-240 g) were randomized into three groups as follows: control group, LPS group (7.5 mg/kg LPS), and LPS+GAL group (5 mg/kg GAL before LPS administration). Histopathological examination of lung specimens obtained 12 h after LPS administration was performed to analyze changes in wet-to-dry (W/D) weight ratio, myeloperoxidase (MPO) activity, and HMGB1 expression level. Additionally, plasma concentrations of tumor necrosis factor-α, interleukin-6, and HMGB1 were measured using an enzyme-linked immunosorbent assay at 0 (baseline), 3, 6, 9, and 12 h after LPS administration. Mortality in the three groups was recorded at 72 h. LPS-induced ALI was characterized by distortion of pulmonary architecture and elevation of MPO activity, W/D weight ratio, and levels of pro-inflammatory cytokines, including tumor necrosis factor-α, interleukin-6, and HMGB1. Pretreatment with GAL significantly reduced the LPS-induced lung pathological changes, W/D weight ratio, levels of pro-inflammatory cytokines and MPO activity (ANOVA). Moreover, GAL treatment significantly decreased the mortality rate (ANOVA). In conclusion, we demonstrated that GAL exerted a protective effect on LPS-induced ALI in rats.

Validation of the Portuguese version of the Evidence-Based Practice Questionnaire / Validação da versão portuguesa do Questionário de Eficácia Clínica e Prática Baseada em Evidências / Validación de la versión portuguesa del Cuestionario de Eficacia Clínica y Práctica Basada en Evidencias

OBJECTIVES: to describe the process of translation and linguistic and cultural validation of the Evidence Based Practice Questionnaire for the Portuguese context: Questionário de Eficácia Clínica e Prática Baseada em Evidências (QECPBE). METHOD: a methodological and cross-sectional study was developed. The translation and back translation was performed according to traditional standards. Principal Components Analysis with orthogonal rotation according to the Varimax method was used to verify the QECPBE's psychometric characteristics, followed by confirmatory factor analysis. Internal consistency was determined by Cronbach's alpha. Data were collected between December 2013 and February 2014. RESULTS: 358 nurses delivering care in a hospital facility in North of Portugal participated in the study. QECPBE contains 20 items and three subscales: Practice (α=0.74); Attitudes (α=0.75); Knowledge/Skills and Competencies (α=0.95), presenting an overall internal consistency of α=0.74. The tested model explained 55.86% of the variance and presented good fit: χ2(167)=520.009; p = 0.0001; χ2df=3.114; CFI=0.908; GFI=0.865; PCFI=0.798; PGFI=0.678; RMSEA=0.077 (CI90%=0.07-0.08). CONCLUSION: confirmatory factor analysis revealed the questionnaire is valid and appropriate to be used in the studied context. .

OBJETIVOS: descrever o processo de tradução e validação linguística e cultural para o contexto português do Questionário de Eficácia Clínica e Prática Baseada em Evidências (QECPBE). MÉTODO: desenvolveu-se um estudo metodológico e transversal. Foi efetuada tradução e retroversão, de acordo com os padrões usuais. Na determinação das características psicométricas do QECPBE utilizou-se a Análise de Componentes Principais com rotação ortogonal, segundo o método Varimax, seguida de análise fatorial confirmatória. A consistência interna foi determinada pelo valor alfa de Cronbach. A coleta de dados ocorreu entre dezembro de 2013 e fevereiro de 2014. RESULTADOS: participaram 358 enfermeiros que exercem a prática clínica num centro hospitalar do norte de Portugal. O QECPBE apresenta 20 itens e três subescalas: Práticas (α=0,74); Atitudes (α=0,75); Conhecimentos/Habilidades e Competências (α=0,95), apresentando consistência interna global de α=0,74. No modelo testado obteve-se variância explicada de 55,86%. O modelo demonstrou um bom ajuste: χ2(167)=520,009; p=0,0001; χ2df=3,114; CFI=0,908; GFI=0,865; PCFI=0,798; PGFI=0,678; RMSEA=0,077 (IC90%=0,07-0,08). CONCLUSÃO: através da análise fatorial confirmatória realizada demonstrou-se que o questionário é válido e adequado para utilização no contexto estudado. .

OBJETIVOS: describir el proceso de traducción y validación lingüística y cultural para el contexto portugués del Cuestionario de Eficacia Clínica y Práctica Basada en Evidencias (CECPBE). MÉTODO: se desarrolló un estudio metodológico y transversal. Fue efectuada traducción y retroversión de acuerdo con los estándares usuales. En la determinación de las características psicométricas del CECPBE se utilizó el Análisis de Componentes Principales con rotación ortogonal, según el método Varimax, seguido por análisis factorial confirmatorio. La consistencia interna fue determinada por el valor alfa de Cronbach. La recolección de datos ocurrió entre diciembre de 2013 y febrero de 2014. RESULTADOS: participaron 358 enfermeros que ejercían la práctica clínica en un centro hospitalario en el norte de Portugal. El CECPBE presenta 20 ítems y tres subescalas: Prácticas (α=0,74); Actitudes (α=0,75); Conocimientos/Habilidades y Competencias (α=0,95), presentando consistencia interna global de α=0,74. En el modelo probado se obtuvo variancia explicada de 55,86%. El modelo demostró un buen ajuste: χ2(167)=520,009; p=0,0001; χ2df=3,114; CFI=0,908; GFI=0,865; PCFI=0,798; PGFI = 0,678; RMSEA = 0,077 (IC90%=0,07-0,08). CONCLUSIÓN: a través del análisis factorial confirmatorio se demostró que el cuestionario es válido y adecuado para utilización en el contexto estudiado. .

Morbilidad y mortalidad de los pacientes con síndrome de distress respiratorio agudo/injuria pulmonar aguda por Influenza A H1N1 que requirieron soporte cardiopulmonar en un hospital general / Morbidity and mortality of patients with acute respiratory distress syndrome/acute pulmonary injury due to influenza A H1N1 who required cardiopulmonary support in a general hospital

Objetivo: Determinar la morbilidad y mortalidad de los pacientes con síndrome de distress respiratorio agudo (SDRA)/injuria pulmonar aguda (IPA) por Influenza A H1N1 que requirieron soporte cardiopulmonar en un hospital general. Material y métodos: Estudio retrospectivo, descriptivo, tipo serie de casos. Se revisaron las historias clínicas, las hojas de monitoreo ventilatorio y hemodinámico de los pacientes con SDRA/IPA secundario a Influenza A H1N1 atendidos en el Servicio de Cuidados Intensivos Generales (SCIG) del Hospital Nacional Cayetano Heredia entre mayo y setiembre de 2009. El diagnóstico de Influenza A H1N1 se realizó por PCR-RT. Resultados: Se atendieron 99 pacientes con Influenza A H1N1, 9 ingresaron al SCIG por SDRA/IPA; cinco requirieron ventilación mecánica invasiva (VMI), tres ventilación mecánica no invasiva y uno no requirió soporte ventilatorio. La edad promedio fue 43,3 ± 18,3 años; el tiempo de enfermedad 8 ± 3 días. Al ingreso, el 100% tuvo fiebre y disnea, el score APACHE II fue 10,5 ± 4,1 y el SOFA 5,6 ± 3,2; el Pa02/Fi02 96,74 ± 28,6. En 4/5 pacientes en VMI el Pa02/Fi02 a las 12 h y al final de la ventilación mecánica fue < 200. La presión en cuña estimada fue 15,69 ± 3,6 y el índice cardiaco por doppler esofágico 2,4 ± 0,34. La TGO fue 160 ± 152,15, DHL 2366,33 ± 1862,13 y CPK 216 ± 298,25. Todos los pacientes recibieron Oseltamivir 150 mg cada 12 h por 10 días. Cuatro pacientes fallecieron. Conclusiones: Los pacientes con SDRA/IPA por Influenza A H1 N1, fueron adultos jóvenes, con tiempo de enfermedad prolongado; con fiebre, disnea y linfopenia; sin compromiso cardiovascular y con hipoxemia refractaria como causa de muerte.

Objective: To determine the morbidity and mortality patterns of patients with acute respiratory distress syndrome (ARDS)/acute pulmonary injury (API) due to influenza A H1N1 who required cardiopulmonary support in a general hospital. Methods: Retrospective case series. Clinical charts, mechanical ventilation and hemodynamic monitoring charts of patients with ARDS/API due to influenza A H1N1 admitted to the general intensive care unit (GICU) of Hospital Nacional Cayetano Heredia from May to September 2009 were reviewed. The diagnosis of influenza H1N1 was confirmed with RT-PCR. Results: 99 patients with influenza A H1N1 were attended; 9 were admitted in the GICU with ARDS/API; five patients required invasive mechanical ventilation (IMV); three non-invasive mechanical ventilation (NIMV) and one did not require ventilatory support. Mean age was 43.3 ± 18.3 years; mean duration of symptoms was 8 ± 3 days. On admission, 100% of patients had fever and dyspnea; mean APACHE II score was 10.5 ± 4.1 and mean SOFA score was 5.6 ± 3.2; the mean Pa02/Fi02 was 96.74 ± 28.6. In 4/5 of patients requiring IMV the Pa02/Fi02 at 12 hours and at the end of mechanical ventilation was < 200. Estimated pulmonary wedge pressure was 15.69 ± 3.6 and the cardiac index estimated by esophageal doppler ultrasound was 2.4 ± 0.34. AST was 160 ± 152.15, LDH was 2366.33 ± 1862.13 and CK was 216 ± 298.25. All patients received oseltamivir 150 mg every 12 hours per 10 days. Four patients died. Conclusions: Patients with ARDS/API due to influenza A H1N1 were young adults with protracted disease with fever and lymphopenia, without cardiovascular involvement and with refractory hypoxemia as the main cause of death.